Shine-On BioMedical Co.,Ltd. (TPEX:6926)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
69.00
+0.30 (0.44%)
Jan 21, 2026, 12:50 PM CST
5.18%
Market Cap3.44B
Revenue (ttm)n/a
Net Income (ttm)-117.07M
Shares Out49.80M
EPS (ttm)-2.36
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume27,006
Average Volume12,920
Open68.70
Previous Close68.70
Day's Range68.70 - 70.00
52-Week Range57.00 - 81.60
Beta-0.03
RSI47.41
Earnings DateNov 14, 2025

About Shine-On BioMedical

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. Shine-On BioMedical Co.,Ltd. was founded in 2021 and is based in Taichung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6926
Full Company Profile

Financial Performance

Financial Statements